Beacon Biomedical, founded with a mission to revolutionize early cancer detection, focuses on developing and commercializing non-invasive, waived tests. Their flagship product, BeScreened-CRC, is a simple blood test designed for colorectal cancer screening, providing an alternative to traditional colonoscopies and fecal-based tests. The company aims to make cancer screening more accessible and convenient, ultimately improving early detection rates and patient outcomes.
Notable figures affiliated with Beacon Biomedical include experienced professionals from the biotech and healthcare sectors. The company has garnered attention from investors committed to advancing medical diagnostics. Key achievements include the successful development and commercialization of BeScreened-CRC, which has had a significant impact on increasing colorectal cancer screening rates, especially during the COVID-19 pandemic when traditional screening methods saw a decline. Beacon Biomedical continues to contribute to the early detection landscape, potentially saving countless lives through earlier intervention.
Beacon Biomedical's most recent funding round was for $366.6k (USD) in March 2018.
As of Mar 13, 2018, Beacon Biomedical has disclosed funding of $391.6k (USD).

Hawkeye Bio
hawkeyebio.com

Early Detection
cancer.us

Harbinger Health

Exact Sciences
exactsciences.com

Helio Health
heliohealth.com

Grail
grail.com

MediBeacon
medibeacon.com

CellMax Life
cellmaxlife.com

Applied Proteomics
OncoHealth
oncohealthcorp.com

Geneoscopy
geneoscopy.com

The Blue Box Biomedical Solutions
thebluebox.ai

Castle Biosciences

Avant Diagnostics

Cellens
cellensinc.com

Mercy BioAnalytics
mercybio.com

Beeken Biomedical

Oncodea
Predictive Biosciences
BioDetego